These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8862279)
1. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients. Dega H; Eliaszewicz M; Gisselbrecht M; Fleury J; Pialoux G; Janssen B; de Saint-Martin L; Gonzalez-Canali G; Dupont B J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):146-54. PubMed ID: 8862279 [TBL] [Abstract][Full Text] [Related]
2. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit? Jo JE; Tang EY; Pua BB Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730 [TBL] [Abstract][Full Text] [Related]
3. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution. Choksi A; Finnegan K; Etezadi V Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370 [TBL] [Abstract][Full Text] [Related]
4. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days. Lee JK; Choi YB J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650 [TBL] [Abstract][Full Text] [Related]
5. Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial. Lesens O; Forestier E; Botelho-Nevers E; Pavese P; David G; Nougarede B; Corbin V; Pereira B; Aumeran C; Sauvat L Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):223-232. PubMed ID: 37993679 [TBL] [Abstract][Full Text] [Related]
6. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation]. Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304 [TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of totally implantable venous access port devices: early and late complications. Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D J BUON; 2015; 20(1):338-45. PubMed ID: 25778336 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors of the Totally Implantable Venous Access Device-Related Infection in Patients With Brain Tumors Undergoing Chemotherapy After Surgery. Li H; Shan J Surg Infect (Larchmt); 2024 Mar; 25(2):133-139. PubMed ID: 38265425 [No Abstract] [Full Text] [Related]
10. [Complications with totally implantable venous access device. A retrospective of 116 cases]. Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448 [TBL] [Abstract][Full Text] [Related]
12. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592 [TBL] [Abstract][Full Text] [Related]
13. Complications related to totally implantable venous access devices in children and adults following lung transplantation. Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770 [TBL] [Abstract][Full Text] [Related]
14. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients]. Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577 [TBL] [Abstract][Full Text] [Related]
15. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441 [TBL] [Abstract][Full Text] [Related]
16. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372 [TBL] [Abstract][Full Text] [Related]
17. Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate. Skiest DJ; Grant P; Keiser P J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):220-6. PubMed ID: 9495221 [TBL] [Abstract][Full Text] [Related]